Oscient Pharmaceuticals (Antara Drug) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 2

Oscient Pharmaceuticals (Antara Drug) General Information

Description

A cholesterol-lowering medicine. The drug is engaged in lowering the cholesterol level in patients. It has the generic name fenofibrate.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Lupin
Primary Office
  • 1000 Winter Street
  • Suite 2200
  • Waltham, MA 02451
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oscient Pharmaceuticals (Antara Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request a free trial

Oscient Pharmaceuticals (Antara Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request a free trial